IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pivotal bioVenture Partners Investment Advisor LLC

Q3 2023 Holdings

Filed 2023-11-13 | 13 holdings | $250.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Karuna Therapeutics IncCOM48576A100$134.8M797,00853.8%
Vaxcyte Inc(PCVX)COM92243G108$40.4M793,03616.1%
Oculis Holding AG(OCS)ORDINARY SHARESH5870P102$24.4M2,218,7549.7%
Inozyme Pharma IncCOM45790W108$18.9M4,494,8517.5%
Rallybio CorpCOM75120L100$8.1M2,404,6443.2%
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$5.9M1,105,3092.3%
Fusion Pharmaceuticals IncCOM36118A100$4.1M1,560,9821.6%
Gracell Biotechnologies IncSPONSORED ADS38406L103$4.0M1,375,0001.6%
Exscientia PLCADS30223G102$3.5M770,5001.4%
Vigil Neuroscience Inc(VIGL)COM92673K108$3.0M560,5951.2%
Bolt Biotherapeutics Inc(BOLT1EUR)COM097702104$2.0M1,891,4670.8%
IO Biotech Inc(IOBT)COM449778109$1.2M864,1970.5%
Aligos Therapeutics IncCOM01626L105$555.2K743,2150.2%